132 related articles for article (PubMed ID: 20685886)
1. Cystic degeneration of macroprolactinoma on long-term cabergoline.
Sharif DA; Nkonge FM; Chawda S; Benjamin J; Stojanović ND
J Clin Endocrinol Metab; 2010 Aug; 95(8):3593-4. PubMed ID: 20685886
[No Abstract] [Full Text] [Related]
2. [Efficacy of cabergoline in the treatment of macroprolactinoma].
Dupuy O; Le Marec E; Mayaudon H; Rilminger H; Bordier L; Bauduceau B
Presse Med; 2003 Jan; 32(2):71-2. PubMed ID: 12653031
[No Abstract] [Full Text] [Related]
3. Tumour shrinkage and chiasmal herniation after successful cabergoline treatment for a macroprolactinoma.
Marcos L; De Luis DA; Botella I; Hurtado A
Clin Endocrinol (Oxf); 2001 Jan; 54(1):126-7. PubMed ID: 11167937
[No Abstract] [Full Text] [Related]
4. A case of postprandial cluster-like headache with prolactinoma: dramatic response to cabergoline.
Negoro K; Kawai M; Tada Y; Ogasawara J; Misumi S; Morimatsu M
Headache; 2005 May; 45(5):604-6. PubMed ID: 15953282
[TBL] [Abstract][Full Text] [Related]
5. [Pharmacologic cure of a pituitary macroprolactinoma].
Hurtado Amador R; Ayala AR
Ginecol Obstet Mex; 2003 Oct; 71():522-6. PubMed ID: 15002692
[TBL] [Abstract][Full Text] [Related]
6. Cabergoline-induced CSF rhinorrhea in patients with macroprolactinoma. Report of three cases.
Cappabianca P; Lodrini S; Felisati G; Peca C; Cozzi R; Di Sarno A; Cavallo LM; Giombini S; Colao A
J Endocrinol Invest; 2001 Mar; 24(3):183-7. PubMed ID: 11314748
[TBL] [Abstract][Full Text] [Related]
7. [Complications of treatment of prolactinoma by dopamine agonists].
Astaf'eva LI; Kadashev BA; Kutin MA; Kalinin PL
Zh Vopr Neirokhir Im N N Burdenko; 2011; 75(2):41-50; discussion 50. PubMed ID: 21793295
[TBL] [Abstract][Full Text] [Related]
8. Resolution of third nerve palsy following treatment of prolactinoma with cabergoline.
Harries AM; Gittoes NJ; Mitchell RD
Acta Neurochir (Wien); 2010 Oct; 152(10):1741-3. PubMed ID: 20623359
[TBL] [Abstract][Full Text] [Related]
9. SUNCT syndrome in a patient with prolactinoma and cabergoline-induced attacks.
Jiménez Caballero PE
Cephalalgia; 2007 Jan; 27(1):76-8. PubMed ID: 17212687
[TBL] [Abstract][Full Text] [Related]
10. Cabergoline treatment in a case of macroprolactinoma after delivery.
Falsetti L
Acta Eur Fertil; 1995; 26(3):105-7. PubMed ID: 9098469
[TBL] [Abstract][Full Text] [Related]
11. Acute shrinkage of a giant prolactinoma, masquerading as an erosive skull base tumour, with cabergoline.
Dash S; Annamalai AK; Simpson HL; Sarkies N; Antoun NM; Mannion R
QJM; 2013 Jan; 106(1):85. PubMed ID: 22075008
[No Abstract] [Full Text] [Related]
12. Pathological gambling associated with cabergoline therapy in a patient with a pituitary prolactinoma.
Davie M
J Neuropsychiatry Clin Neurosci; 2007; 19(4):473-4. PubMed ID: 18070857
[No Abstract] [Full Text] [Related]
13. Prolactin serum concentrations after electroconvulsive therapy in a depressed patient with cabergoline-treated prolactinoma: implications for treatment.
Feneberg E; Gahr M; Baumgarten E; Connemann B; Merger S; Özpeynirci Y; Schönfeldt-Lecuona C
J ECT; 2015 Jun; 31(2):e28-9. PubMed ID: 26000778
[No Abstract] [Full Text] [Related]
14. Macroprolactinoma associated with Cushing's disease, successfully treated with cabergoline.
T'Sjoen G; Defeyter I; Van De Saffele J; Rubens R; Vandeweghe M
J Endocrinol Invest; 2002 Feb; 25(2):172-5. PubMed ID: 11929090
[TBL] [Abstract][Full Text] [Related]
15. Reduction in the size of prolactin-producing pituitary tumor after Cabergoline administration.
Melis GB; Gambacciani M; Paoletti AM; Mais V; Sghedoni D; Fioretti P
Fertil Steril; 1989 Sep; 52(3):412-5. PubMed ID: 2570719
[TBL] [Abstract][Full Text] [Related]
16. Macular amyloidosis complicating macroprolactinoma--a novel clinical association.
Dutta D; Ahuja A; Sharma L; Bhardwaj M; Kulshreshtha B
Endokrynol Pol; 2015; 66(6):555-8. PubMed ID: 26662655
[TBL] [Abstract][Full Text] [Related]
17. High dose cabergoline therapy for a resistant macroprolactinoma during pregnancy.
Banerjee A; Wynne K; Tan T; Hatfield EC; Martin NM; Williamson C; Meeran K
Clin Endocrinol (Oxf); 2009 May; 70(5):812-3. PubMed ID: 18803677
[No Abstract] [Full Text] [Related]
18. Massive reduction of tumour load and normalisation of hyperprolactinaemia after high dose cabergoline in metastasised prolactinoma causing thoracic syringomyelia.
van Uum SH; van Alfen N; Wesseling P; van Lindert E; Pieters GF; Nooijen P; Hermus AR
J Neurol Neurosurg Psychiatry; 2004 Oct; 75(10):1489-91. PubMed ID: 15377706
[TBL] [Abstract][Full Text] [Related]
19. A man with breast discharge and headache.
Maiti A; Das A; Chatterjee S
Eur J Intern Med; 2016 Apr; 29():e3-4. PubMed ID: 26577222
[No Abstract] [Full Text] [Related]
20. Cerebrospinal fluid rhinorrhea occurring in long-term bromocriptine treatment for macroprolactinomas.
Eljamel MS; Foy PM; Swift AC; MacFarlane IA
Surg Neurol; 1992 Oct; 38(4):321. PubMed ID: 1440226
[No Abstract] [Full Text] [Related]
[Next] [New Search]
